ABCC9/SUR2 in the brain: Implications for hippocampal sclerosis of aging and a potential therapeutic target.

作者: Peter T. Nelson , Gregory A. Jicha , Wang-Xia Wang , Eseosa Ighodaro , Sergey Artiushin

DOI: 10.1016/J.ARR.2015.07.007

关键词:

摘要: The ABCC9 gene and its polypeptide product, SUR2, are increasingly implicated in human neurologic disease, including prevalent diseases of the aged brain. SUR2 proteins a component ATP-sensitive potassium ("KATP") channel, metabolic sensor for stress and/or hypoxia that has been shown to change aging. KATP channel also helps regulate neurovascular unit. Most brain cell types express neurons, astrocytes, oligodendrocytes, microglia, vascular smooth muscle, pericytes, endothelial cells. Thus it is not surprising variants associated with risk diseases. For example, Cantu syndrome result mutations; we discuss manifestations this genetic syndrome. More common disorders linked include hippocampal sclerosis aging (HS-Aging), sleep disorders, depression. HS-Aging neurological disease pathologic features both neurodegenerative (aberrant TDP-43) cerebrovascular (arteriolosclerosis) disease. As potential therapeutic intervention, pharmacopeia agonists antagonists, so ABCC9/SUR2 may provide "druggable target", relevant perhaps Alzheimer's We conclude more work required better understand roles during health conditions.

参考文章(238)
Dorothy K Grange, Colin G Nichols, Gautam K Singh, Cantú Syndrome and Related Disorders University of Washington, Seattle. ,(2014)
Chun Jiang, Yun Shi, Wei-Wei Shi, Yang Yang, KATP channel action in vascular tone regulation: from genetics to diseases Acta Physiological Sinica. ,vol. 64, pp. 1- 13 ,(2012)
James B. Leverenz, Anne M. Lipton, Clinical aspects of hippocampal sclerosis. Handbook of Clinical Neurology. ,vol. 89, pp. 565- 567 ,(2008) , 10.1016/S0072-9752(07)01252-3
Yun Cai, Dong Chai, Fei Pei, Yi Fang, Rui Wang, Bei-bei Liang, Wen-yu Cui, Cun-gang Bao, Hai Wang, Single-dose pharmacokinetics and safety of iptakalim hydrochloride in Chinese healthy volunteers. Journal of Pharmacy and Pharmacology. ,vol. 64, pp. 337- 343 ,(2012) , 10.1111/J.2042-7158.2011.01411.X
Willa D. Brenowitz, Sarah E. Monsell, Frederick A. Schmitt, Walter A. Kukull, Peter T. Nelson, Hippocampal Sclerosis of Aging is a Key Alzheimer's Disease Mimic: Clinical-Pathologic Correlations and Comparisons with both Alzheimer's Disease and Non-Tauopathic Frontotemporal Lobar Degeneration Journal of Alzheimer's Disease. ,vol. 39, pp. 691- 702 ,(2014) , 10.3233/JAD-131880
Frank N. Salamone, Ming Zhou, Anthony Auerbach, Cell-type specific expression of ATP-sensitive potassium channels in the rat hippocampus. The Journal of Physiology. ,vol. 514, pp. 327- 341 ,(1999) , 10.1111/J.1469-7793.1999.315AE.X
W. R. Brown, C. R. Thore, Review: cerebral microvascular pathology in ageing and neurodegeneration. Neuropathology and Applied Neurobiology. ,vol. 37, pp. 56- 74 ,(2011) , 10.1111/J.1365-2990.2010.01139.X
G KANE, X LIU, S YAMADA, T OLSON, A TERZIC, Cardiac KATP channels in health and disease Journal of Molecular and Cellular Cardiology. ,vol. 38, pp. 937- 943 ,(2005) , 10.1016/J.YJMCC.2005.02.026
Dong Liu, Michael Pitta, Jong-Hwan Lee, Balmiki Ray, Debomoy K Lahiri, Katsutoshi Furukawa, Mohamed Mughal, Haiyang Jiang, Julissa Villarreal, Roy G Cutler, Nigel H Greig, Mark P Mattson, None, The KATP channel activator diazoxide ameliorates amyloid-β and tau pathologies and improves memory in the 3xTgAD mouse model of Alzheimer's disease. Journal of Alzheimer's Disease. ,vol. 22, pp. 443- 457 ,(2010) , 10.3233/JAD-2010-101017
Peter T. Nelson, Erin L. Abner, Frederick A. Schmitt, Richard J. Kryscio, Gregory A. Jicha, Charles D. Smith, Daron G. Davis, John W. Poduska, Ela Patel, Marta S. Mendiondo, William R. Markesbery, Modeling the association between 43 different clinical and pathological variables and the severity of cognitive impairment in a large autopsy cohort of elderly persons. Brain Pathology. ,vol. 20, pp. 66- 79 ,(2010) , 10.1111/J.1750-3639.2008.00244.X